TFGT
AXDX

TS Financial Group (TSFG)’s Accelerate Diagnostics AXDX Stock Holding History

TS Financial Group (TSFG)’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed -$17K – 840
2019
Q4 		$17K Buy
+100
New +$16.5K 0.01% 342

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

TS Financial Group (TSFG)'s AXDX Position: Q1 2020 in Review

TS Financial Group (TSFG) sold out of Accelerate Diagnostics (AXDX) in Q1 2020, closing a stake of 100 shares — an estimated $17K sold.

TS Financial Group (TSFG) first reported a position in AXDX in Q4 2019 and held it in 1 quarter. The position peaked at $17K in Q4 2019. 110 funds tracked by Wall St. Rank hold AXDX as of Q1 2020.

  • TS Financial Group (TSFG) reported no remaining Accelerate Diagnostics position as of Q1 2020 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 100 Accelerate Diagnostics shares in Q1 2020, an estimated $17K.
  • TS Financial Group (TSFG) first reported a position in Accelerate Diagnostics in Q4 2019 and held it in 1 quarter.
  • TS Financial Group (TSFG)'s Accelerate Diagnostics position peaked at $17K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2020.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2020, filed 8 Apr 2020.